Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. - Wikidata - wikimedia - TriplyDB

Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.

Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.

http://www.wikidata.org/entity/Q41676756

about

Declining blood collection and utilization in the United States.Blood transfusion safety: A study of adverse reactions at the blood bank of a tertiary care center Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network.Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Custodes invicem custodiunt (the watchmen can watch each other)Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in Korea Genotype frequency of human neutrophil antigen-3 polymorphisms in the Yi, Han, and Tibetan populations of China Transfusion monitoring: care practice analysis in a public teaching hospital.How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis.ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.Continued decline in blood collection and transfusion in the United States-2015 Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.Red cell alloimmunisation in patients with different types of infections.Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy.Supplemental findings from the National Blood Collection and Utilization Surveys, 2013 and 2015.Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies.Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.Centrifugation-free washing: A novel approach for removing IgA from stored red blood cells.Analysis of pediatric adverse reactions to transfusions.Incidence, risk factors, and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study.Platelet proteins cause basophil histamine release through an immunoglobulin-dependent mechanism.Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.

P2860

Q30152037-3F65AF11-E7A6-455E-BF72-338698C0A514 Q33457829-4A56ED14-86BA-49E3-BA9A-238A615AE440 Q33458683-2424E347-B53F-4213-9BDB-CFDCF58B74F4 Q33841435-D136D620-DC32-462A-B597-EF80D1C35825 Q36237988-19F2DAB0-34DD-4A12-8CEE-B421A4217B17 Q36419679-76551EAE-E4A7-4330-BC1B-6799E6E9D26E Q36664976-C38846FD-371E-497A-B5C5-55B6A3997F0F Q36916863-08BEB2B6-B07E-4145-B66E-91F97BAFEF45 Q38565438-63D51980-2EB9-47F3-A1CB-EDB5AE51C573 Q38711023-68824AE1-F8FC-4E40-AB9F-30CA124F6A80 Q38738078-9E3BD103-6619-4610-B69B-554DEDBB6B6F Q38819188-27B158A6-5C03-4D5F-8957-0284D6929362 Q40092045-8CB6AB08-D77F-44BD-A9FD-0C4F57888723 Q40098378-DE17ADF7-CE20-485E-8F5D-8D59644AC2B9 Q40157879-ACBC8DFA-21C6-41A7-BEAF-06200F4F1D89 Q40181495-0C9D3926-11B3-481A-8F5F-831654A7055F Q40186836-62EE231B-9362-4EB8-8A3B-EB9C908D661A Q40307332-94D9D931-9C29-4C14-BD11-A4D4A3176EBA Q46263450-AB3E7477-27C6-4F72-BC43-5FD6BBC7622B Q47212997-55D950C7-D5F3-4D02-A134-55BB7A8A5AC3 Q47921538-35BE01D3-2CB2-4F9D-88BF-7AD992520C10 Q48120481-5864BC25-3C12-4E84-81FB-8F357E141352 Q51021097-E1A6A613-5E58-44DD-A91C-EB8240DB057B Q51726548-D0BBB544-008E-46A7-BDC2-D077FDDE37CC

P2860

Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.

http://www.wikidata.org/entity/Q41676756

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Transfusion-related adverse re ...... , United States, 2010 to 2012.

@en

type

label

Transfusion-related adverse re ...... , United States, 2010 to 2012.

@en

prefLabel

Transfusion-related adverse re ...... , United States, 2010 to 2012.

@en

P1433

Q41676756-71D7F2B4-D47D-44D4-9017-63351A419F07

P1476

Q41676756-D758E9E1-0823-4F95-B28C-3816E0226D41

P2093

Q41676756-1AE9B552-6CB2-42A3-8E5D-987881AD35C9

Q41676756-819F38FD-6793-4048-95A4-8AF76D0FE431

Q41676756-F529372B-0CD9-4D72-BA95-35A271067518

P2860

Q41676756-05F61CC0-FA5E-4AB9-BB20-38C969C832F6

Q41676756-0D260468-BD42-48B9-A321-5A5170BA40E4

Q41676756-1AEF348C-019E-47CE-97AE-D507F9069816

Q41676756-1E4F31E7-471D-42E8-B3BB-00909D5D2930

Q41676756-263BC9D5-7E53-4E59-80CB-A62017A0D8B2

Q41676756-2CC37BE1-BF85-46C3-986F-260C85296938

Q41676756-38AC3932-3A25-438E-B9B0-E3C113482DDC

Q41676756-39D006D3-8945-4E7E-BE57-FAA0CA58EAFE

Q41676756-46F8AF1F-339B-4912-A637-33B85DDE732F

Q41676756-4E0B7888-2112-4CCE-82C6-EE3D0EB806F3

P304

Q41676756-91B12366-2125-4388-A2AD-E05C43582C1E

P31

Q41676756-0F9FF4F8-4652-4981-96EA-BDEB94B6C425

P356

Q41676756-BBF567BD-1982-4449-BF4B-AD48F8E8332C

P433

Q41676756-0513A183-1F85-4889-9014-A8DA1E1CB7D9

P478

Q41676756-66C54E21-A7C2-4EB7-A05F-065E507EEA1D

P50

Q41676756-38B6F1E7-18AA-4A4A-BF0B-7915B0E066D8

P577

Q41676756-7F3A5097-43B9-4FF0-8E3F-3CCA265EAFD1

P5875

Q41676756-5AFFE1D8-3CB2-4A2A-9D03-D723A9C881B8

P698

Q41676756-B7AB320F-2EB3-494A-B9A3-2A4A11420459

P356

P1433

P1476

Transfusion-related adverse re ...... , United States, 2010 to 2012.

@en

P2093

Alexis R Harvey

http://www.w3.org/2001/XMLSchema#string

Koo-Whang Chung

http://www.w3.org/2001/XMLSchema#string

Sridhar V Basavaraju

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of the surveillance and reporting of central line-associated bloodstream infection denominator data.

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Validation of the surveillance and reporting of central line-associated bloodstream infection data to a state health department.

Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system.

French Haemovigilance Data on Platelet Transfusion.

Completeness of communicable disease reporting, North Carolina, USA, 1995-1997 and 2000-2006.

The European Blood Directive: a new era of blood regulation has begun.

The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007

Participation rates in epidemiologic studies.

Transfusion practice and safety: current status and possibilities for improvement.

P304

709-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12918

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Kuehnert

P577

2014-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267874049

http://www.w3.org/2001/XMLSchema#string

P698

25371300

http://www.w3.org/2001/XMLSchema#string